Theraclone Sciences Secures $10,600,000 Series B Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8bdff59f-085c-4298-9c99-e9ec583e7c81&Preview=1 -
Date
9/8/2011 -
Company Name
Theraclone Sciences -
Mailing Address
1124 Columbia Street Seattle, WA 98104 -
Company Description
Theraclone Sciences is a discovery-stage biotech developing novel therapeutic antibodies for the treatment of infectious disease and inflammation. Our proprietary discovery platform allows us to comprehensively screen and identify the rare antibodies that select individuals produce to successfully ward off disease. -
Website
http://www.Theraclone-Sciences.com -
Transaction Type
Venture Equity -
Transaction Amount
$10,600,000 -
Transaction Round
Series B -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
ARCH Venture Partners -
Venture Investor
Canaan Partners -
Venture Investor
HealthCare Ventures -
Venture Investor
MPM Capital -
Venture Investor
Alexandria Real Estate Equities -
Venture Investor
Amgen Ventures
